AMRX R&D Expense Growth
Amneal Pharmaceuticals Inc Class A · R&D Expense Growth
AMRX R&D Expense Growth
Latest reported-2.38%period ending
AMRX FY R&D Growth (YoY) (0.00% → -2.38%)
Latest values, visible window
High-resolution chart · PNG
AMRX r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -2.38% | |
| -2.0724% | |
| -6.6655% | |
| -0.4319% | |
| 9.9578% | |
| -5.7849% | |
| -3.8793% | |
| 9.6453% | |
| -6.256% | |
| 49.5923% | |
| 28.2335% | |
| 0% |